Laserfiche WebLink
INTERMEDIX HOLDINGS INC. AND SUBSIDIARIES <br />Notes to Consolidated Financial Statements <br />December 31, 2010 <br />or any portion of any unvested options to immediately vest and become exercisable upon a sale of the <br />Company or at such other time as the BOD may elect. <br />Stock -based compensation expense is shown as an individual line on the accompanying consolidated <br />statements of operations. The allocation of stock -based expense between "Cost of revenues" and "Selling, <br />general and administrative expenses" for the Successor Period is as follows (in thousands): <br />Cost of revenues $ 221 <br />Selling, general and administrative expenses 595 <br />Total stock -based <br />compensation expense $ 816 <br />The Company accounts for its equity -based awards using ASC Topic 718. This statement requires entities <br />to measure compensation expense for all equity -based awards granted, modified, or settled using the <br />fair -value measurement method and to recognize the costs in income over the requisite service period, <br />which is generally the vesting period. The Company has elected to recognize these costs on a straight -line <br />basis. <br />The fair value of each stock option award is estimated on the date of grant using BSM option - pricing <br />model. The weighted average grant -date value of each option grant awarded during the Successor Period <br />was as follows: <br />Weighted average grant -date value <br />of options granted $ 118.95 <br />Assumptions: <br />Risk -free rate of return 1.73% <br />Expected life in years 6.50 <br />Expected volatility 47.5% <br />Expected dividend yield $ — <br />The risk free rate of return is determined based on a yield curve of U.S. Treasury rates ranging from 5 to <br />7 years which is the period commensurate with the expected life of options granted. Expected life in years <br />is calculated using the simplified method, as permitted under ASC Topic 718, given the Company's lack of <br />historical experience with respect to the lives of options granted and post- vesting termination patterns. <br />Since the Company has no historical basis for determining its own volatility, the expected volatility is <br />established based on a peer group comprising companies similar to that of the Company. The expected <br />dividend yield is zero as the Company has not paid any cash dividends and does not anticipate it will do so <br />in the foreseeable future. <br />31 (Continued) <br />